6:27 AM ET
8-K
Capital Raise
ADC Therapeutics Capital Raise of $86.6M
ADC Therapeutics entered into securities purchase agreements for a $86.6 million private placement (PIPE) involving the sale of 12.9 million common shares and 48.1 million pre-funded warrants. The financing included participation from new investor Bain Capital Life Sciences and existing investors Redmile, TCGX, and Nantahala Capital. Proceeds will be used to fund ZYNLONTA pipeline studies and extend the company's cash runway into 2029.
- Value
- $86.6M
- Counterparty
- Bain Capital Life Sciences